Patent & IP Valuation: Relief from Royalty, Excess Earnings & Multi-Period Methods | Virtual Auditor

Patent & IP Valuation: Relief from Royalty, Excess Earnings & Multi-Period Methods

Featured Answer: Intellectual property valuation in India relies on three primary approaches — the income approach (Relief from Royalty and Multi-Period Excess Earnings methods), the market approach, and the cost approach (reproduction and replacement cost). For patents, the Relief from Royalty method estimates fair value by calculating the present value of hypothetical royalty payments the owner avoids by owning the IP. The MPEEM isolates excess earnings attributable to a specific intangible asset after deducting contributory asset charges. Ind AS 38 governs recognition and measurement of intangible assets, while Section 32(1)(ii) of the Income Tax Act provides depreciation benefits on acquired IP.

Intellectual property — patents, trademarks, copyrights, and trade secrets — represents an increasingly significant portion of enterprise value in the modern economy. Whether for financial reporting under Ind AS 38, purchase price allocation in business combinations, transfer pricing compliance, litigation support, or strategic decision-making, robust IP valuation is essential. This guide provides a deep technical examination of IP valuation methodologies, regulatory requirements, and practical considerations specific to the Indian context.

At Virtual Auditor, CA V. Viswanathan — an IBBI Registered Valuer — provides comprehensive IP and intangible asset valuation services for financial reporting, M&A transactions, transfer pricing, and dispute resolution.

1. Types of Intellectual Property Subject to Valuation

Definition: Intellectual property (IP) refers to creations of the mind — inventions, literary and artistic works, designs, symbols, names, and images used in commerce — that are protected by law through patents, copyrights, trademarks, and trade secrets. IP valuation is the process of estimating the economic value of these intangible assets using recognised financial methodologies.

1.1 Patents

A patent grants the holder exclusive rights to manufacture, use, sell, and license an invention for a specified period (20 years from the filing date under the Indian Patents Act, 1970). Patent valuation is required in contexts including:

  • Licensing negotiations and royalty rate determination.
  • Purchase price allocation following a business combination (Ind AS 103).
  • Infringement damages quantification in litigation.
  • Transfer pricing documentation for cross-border IP transfers.
  • Collateral valuation for IP-backed financing.

1.2 Trademarks

Trademarks protect brand names, logos, and distinguishing marks. Unlike patents, trademarks can have indefinite useful lives if properly maintained through renewal. Trademark valuation is particularly relevant in franchise arrangements, brand licensing, and M&A transactions where brand value constitutes a significant portion of the deal consideration.

1.3 Copyrights

Copyrights protect original literary, dramatic, musical, and artistic works, as well as software code. Under the Indian Copyright Act, 1957, the protection period is 60 years from the author’s death (for literary, dramatic, musical, and artistic works) or 60 years from publication (for photographs, films, and sound recordings). Software copyright valuation has gained prominence with the growth of India’s IT sector.

1.4 Trade Secrets

Trade secrets include proprietary formulations, processes, customer lists, and other confidential business information. Unlike other forms of IP, trade secrets derive value from their secrecy and have no fixed statutory protection period. Valuation of trade secrets is inherently challenging due to the absence of public disclosure and the binary risk of value destruction upon disclosure.

2. Valuation Approaches: An Overview

IP valuation methodologies broadly fall under three approaches, consistent with the International Valuation Standards (IVS) framework:

  • Income approach: Estimates value based on the present value of future economic benefits attributable to the IP. Primary methods include Relief from Royalty (RfR) and Multi-Period Excess Earnings (MPEEM).
  • Market approach: Derives value from comparable transactions involving similar IP assets. Limited applicability due to the unique nature of most IP and the lack of transparent transaction data in India.
  • Cost approach: Estimates value based on the cost to recreate or replace the IP. Includes reproduction cost (exact replica) and replacement cost (equivalent utility) methods.

The choice of method depends on the type of IP, the purpose of valuation, data availability, and the stage of the IP lifecycle. In practice, valuers often apply multiple methods and reconcile the results for a supportable conclusion.

3. Relief from Royalty Method (RfR)

3.1 Conceptual Framework

The Relief from Royalty method — also known as the Royalty Savings method — is the most widely applied income approach for valuing patents and trademarks. The underlying premise is that the IP owner is “relieved” from paying royalties to a third party for the right to use the IP. The value of the IP equals the present value of the hypothetical royalty payments that the owner avoids.

3.2 Step-by-Step Application

  1. Project future revenues: Estimate the revenue stream attributable to the IP over its remaining useful life. For patents, this is limited to the remaining statutory life or economic life, whichever is shorter.
  2. Select an appropriate royalty rate: Determine the royalty rate that an arm’s length licensee would pay. Sources include:
    • Comparable licence agreements (from databases such as RoyaltyStat, ktMINE, or publicly filed agreements).
    • Industry benchmarks published by organisations like the World Intellectual Property Organisation (WIPO).
    • The 25% rule of thumb (now largely discredited post-Uniloc in the US but still used directionally in India).
    • Profit split analysis based on the relative contribution of the IP to total profits.
  3. Calculate royalty savings: Multiply projected revenues by the selected royalty rate to derive annual royalty savings.
  4. Deduct tax: Apply the applicable corporate tax rate to the royalty savings to determine after-tax royalty savings.
  5. Apply a discount rate: Discount the after-tax royalty savings to present value using an appropriate discount rate. The discount rate for intangible assets is typically higher than the weighted average cost of capital (WACC) to reflect the higher risk profile of IP.
  6. Add tax amortisation benefit (TAB): If the IP is depreciable for tax purposes (Section 32(1)(ii) — discussed below), add the present value of the tax shield from amortisation.

3.3 Royalty Rate Selection: Critical Considerations

The royalty rate is the single most influential variable in the RfR method. Key considerations include:

  • Comparability: Licence agreements must be comparable in terms of the type of IP, industry, geography, exclusivity, and scope of rights granted.
  • Arm’s length standard: Rates from related-party agreements must be adjusted to arm’s length. The OECD Transfer Pricing Guidelines and Indian transfer pricing rules (Chapter X of the Income Tax Act) provide guidance.
  • Profit margin analysis: Cross-check the royalty rate against the licensee’s expected profit margins. A royalty rate that eliminates licensee profitability is unsustainable.
  • Technology lifecycle: Early-stage technologies with high growth potential may command higher rates than mature technologies approaching obsolescence.
Expert Tip — CA V. Viswanathan: In Indian IP valuations, we frequently encounter the challenge of limited comparable licence data, particularly for niche technologies and domestic-only trademarks. In such cases, I recommend a triangulation approach — combine available licence data (even international comparables with appropriate adjustments) with a profit split analysis and a top-down margin analysis. Document the rationale thoroughly, as auditors and tax authorities will scrutinise the royalty rate selection closely.

3.4 Useful Life and Discount Rate

Useful life: For patents, the remaining statutory life (20 years from filing minus elapsed time) provides an outer bound. However, economic useful life may be shorter due to technological obsolescence, competitive dynamics, or market shifts. For trademarks with indefinite legal lives, economic useful life analysis considers brand relevance, market dynamics, and management intent to maintain the mark.

Discount rate: The discount rate for IP typically falls between the WACC and the internal rate of return (IRR) implied by the transaction. The AICPA’s Practice Aid on Intangible Asset Valuation recommends building up from the WACC by adding a premium for IP-specific risk. In India, discount rates for patent valuations typically range from 15% to 25%, depending on the technology’s maturity and commercial viability.

4. Multi-Period Excess Earnings Method (MPEEM)

4.1 When to Use MPEEM

The MPEEM is typically applied to value the primary intangible asset in a group of assets — most commonly customer relationships, but also applicable to patented technology when it is the dominant value driver. It is the preferred method for purchase price allocation under Ind AS 103 (Business Combinations) where the intangible asset generates identifiable cash flows.

4.2 Methodology

The MPEEM isolates the earnings attributable to the subject intangible asset by deducting returns (contributory asset charges) for all other assets — tangible and intangible — that contribute to the cash flow stream:

  1. Project total cash flows: Forecast revenues, operating expenses, and capital expenditure for the business unit or product line utilising the IP.
  2. Identify contributory assets: List all assets (net working capital, fixed assets, assembled workforce, other intangible assets) that contribute to the projected cash flows.
  3. Calculate contributory asset charges (CACs): For each contributory asset, estimate a fair return — typically the asset’s fair value multiplied by an appropriate rate of return. CACs are deducted from the total cash flows.
  4. Derive excess earnings: The residual cash flow after deducting all CACs represents the earnings attributable to the subject intangible asset.
  5. Discount to present value: Apply a discount rate specific to the intangible asset (higher than WACC) to the excess earnings stream.
  6. Add tax amortisation benefit: If applicable, add the present value of the tax amortisation benefit.

4.3 Contributory Asset Charges: Practical Guidance

The determination of CACs is the most technically demanding aspect of MPEEM. Key principles include:

  • Net working capital: Apply the pre-tax cost of debt or a blended rate reflecting the risk profile of working capital components.
  • Fixed assets (property, plant & equipment): Apply a rate that covers both the return of the asset (depreciation) and the return on the asset (a fair rate of return on fair value).
  • Assembled workforce: Although not separately recognised under Ind AS 38, an assembled workforce is a contributory asset. Its fair value is typically estimated using the cost approach (recruitment and training costs), and the CAC is calculated using a return on and return of the asset.
  • Other intangible assets: If the entity holds multiple intangible assets (e.g., trademark and patent), the fair value of the non-subject intangible must be determined separately (often via RfR) and a CAC applied.

4.4 MPEEM vs. RfR: Choosing the Right Method

The RfR method is generally preferred for patents and trademarks where comparable licence data exists. MPEEM is preferred for customer relationships and for the primary intangible asset in a purchase price allocation where licence data is unavailable. In practice, many valuers apply both methods and reconcile the results, using the RfR as a reasonableness check on MPEEM outputs.

5. Cost Approach: Reproduction vs. Replacement Cost

5.1 Reproduction Cost Method

This method estimates the cost of creating an exact replica of the IP asset, including all the same features, design elements, and functionality. It includes:

  • Direct costs — R&D expenditure, materials, and labour.
  • Indirect costs — management time, overheads, and facilities.
  • Developer’s profit — a fair return on the investment required to recreate the asset.
  • Opportunity cost — the cost of foregone revenue during the recreation period.

From the total reproduction cost, deductions are made for functional obsolescence (if the IP’s functionality has been superseded), economic obsolescence (if external factors have reduced the IP’s value), and physical deterioration (if applicable).

5.2 Replacement Cost Method

This method estimates the cost of creating an asset with equivalent utility — it need not be an exact replica. For example, replacing a patented chemical process might involve developing an alternative process that achieves the same output at the same cost. The replacement cost method is generally preferred when the exact specification of the IP is less important than its functional outcome.

5.3 Limitations of the Cost Approach

The cost approach has inherent limitations for IP valuation:

  • It does not capture the economic benefits (income potential) of the IP — cost does not equal value.
  • It is difficult to estimate obsolescence deductions objectively.
  • It is most appropriate for recently developed IP with limited commercial track record.

Despite these limitations, the cost approach serves as a useful floor valuation and cross-check for income approach methods.

6. Ind AS 38: Intangible Asset Recognition and Measurement

6.1 Recognition Criteria

Under Ind AS 38 (Intangible Assets), an intangible asset is recognised only when:

  • It is identifiable — either separable from the entity or arising from contractual or legal rights.
  • The entity controls the asset — it has the power to obtain future economic benefits and restrict others’ access.
  • Future economic benefits are probable.
  • The cost can be measured reliably.

6.2 Internally Generated vs. Acquired Intangibles

Ind AS 38 imposes a critical distinction:

  • Acquired intangible assets (through purchase or business combination) are recognised at fair value on the acquisition date. This is where IP valuation methodologies — RfR, MPEEM, cost approach — are applied for purchase price allocation under Ind AS 103.
  • Internally generated intangible assets are subject to stringent recognition criteria. Research phase expenditure is always expensed. Development phase expenditure can be capitalised only when all six conditions of Ind AS 38.57 are met (technical feasibility, intention to complete, ability to use or sell, probable future benefits, adequate resources, and reliable cost measurement).
  • Internally generated brands, mastheads, customer lists, and similar items are never capitalised, as Ind AS 38 specifically prohibits their recognition.

6.3 Subsequent Measurement

After initial recognition, intangible assets are measured under either:

  • Cost model: Carried at cost less accumulated amortisation and impairment losses.
  • Revaluation model: Permitted only if an active market exists for the asset — which is rare for IP in India.

Amortisation is charged over the useful life of the asset. If the useful life is indefinite (e.g., certain trademarks), no amortisation is charged, but an annual impairment test is mandatory under Ind AS 36.

7. Section 32(1)(ii): Tax Depreciation on Intellectual Property

Under Section 32(1)(ii) of the Income Tax Act, 1961, depreciation is allowed on intangible assets — including patents, copyrights, trademarks, licences, franchises, and any other business or commercial rights of similar nature — at 25% on a written-down value (WDV) basis. Key points:

  • The asset must be acquired (purchased or obtained through a business combination). Internally developed IP may not qualify for depreciation under this provision unless capitalised in the books.
  • The depreciation is available from the year in which the asset is first put to use.
  • The 25% WDV rate results in the asset being substantially depreciated over approximately 8-10 years.
  • In purchase price allocations, the tax amortisation benefit (TAB) arising from Section 32(1)(ii) depreciation is added to the pre-TAB fair value to arrive at the final valuation. The TAB factor for a 25% WDV rate at typical discount rates ranges from 1.10 to 1.20.

8. Transfer Pricing Implications: DEMPE Analysis

8.1 The DEMPE Framework

Cross-border transfers of IP between related parties are subject to transfer pricing regulations under Chapter X of the Income Tax Act. The OECD’s BEPS Action 8-10 guidance, increasingly adopted by Indian transfer pricing authorities, requires that the allocation of IP-related returns be based on the DEMPE functions — Development, Enhancement, Maintenance, Protection, and Exploitation of the IP.

Each entity in the multinational group that performs DEMPE functions, contributes assets, and assumes risks related to the IP is entitled to an arm’s length return commensurate with its contribution. Legal ownership alone does not entitle an entity to the full return from the IP.

8.2 Application in Indian Transfer Pricing

Indian transfer pricing officers have increasingly adopted the DEMPE framework in assessments. Key areas of focus include:

  • R&D cost-sharing arrangements: Whether the Indian entity’s contribution to R&D is commensurate with the benefits received.
  • Royalty payments to foreign AEs: Whether the royalty rate is arm’s length given the DEMPE functions performed by the Indian entity.
  • IP migration: Transfers of IP out of India (e.g., through restructuring) are scrutinised for appropriate exit charges.
  • Marketing intangibles: Indian entities performing significant advertising, marketing, and promotion (AMP) functions may be entitled to ownership or co-ownership of marketing intangibles, leading to potential transfer pricing adjustments.

For comprehensive transfer pricing advisory services, including DEMPE analysis and IP-related documentation, contact Virtual Auditor.

8.3 Valuation for Transfer Pricing Purposes

When IP is transferred between related parties (through sale, licence, or cost-contribution arrangement), the transfer must be at arm’s length. The most appropriate method depends on the nature of the transfer:

  • Comparable Uncontrolled Price (CUP): If comparable licence agreements exist.
  • Transactional Net Margin Method (TNMM): For ongoing royalty arrangements where direct comparables are unavailable.
  • Profit Split Method: For highly integrated operations where DEMPE functions are shared between jurisdictions.
  • Discounted Cash Flow (DCF): For lump-sum IP transfers, using the income approach (RfR or MPEEM) to estimate arm’s length consideration.

9. WIPO Guidelines and International Best Practices

The World Intellectual Property Organisation (WIPO) provides guidance on IP valuation, particularly for developing countries. Key principles from WIPO’s framework include:

  • Purpose-driven valuation: The purpose of the valuation (financial reporting, licensing, litigation, financing) determines the appropriate standard of value and methodology.
  • Multiple method reconciliation: WIPO recommends applying at least two methods and reconciling the results to arrive at a robust conclusion.
  • Qualitative factors: Beyond quantitative analysis, valuers should consider the strength of IP protection (patent claims breadth, trademark distinctiveness), the competitive landscape, and the IP’s strategic importance to the business.
  • Documentation standards: Comprehensive documentation of assumptions, data sources, and methodological choices is essential for defensibility.

10. IP Valuation for Litigation and Damages Quantification

10.1 Patent Infringement Damages

In patent infringement litigation, the patentee may claim damages based on:

  • Lost profits: The profits the patentee would have earned but for the infringement. This requires demonstrating that the patentee would have made the infringer’s sales (the “but-for” analysis).
  • Reasonable royalty: The royalty that the patentee and infringer would have agreed upon in a hypothetical negotiation at the time the infringement began. The Relief from Royalty method is directly applicable here.
  • Unjust enrichment: The profits earned by the infringer attributable to the patented invention, available under Section 108 of the Indian Patents Act.

10.2 Trademark Infringement and Passing Off

Damages in trademark cases may include lost profits, damage to brand reputation (brand dilution), and corrective advertising costs. Valuation of brand dilution requires estimating the reduction in the trademark’s fair value caused by the infringing activity — typically using a “before and after” valuation approach.

10.3 Expert Witness Standards

IP valuation experts appearing as witnesses in Indian courts must comply with the evidentiary standards of the Indian Evidence Act, 1872 (now Bharatiya Sakshya Adhiniyam, 2023). The valuation must be based on reliable data, accepted methodologies, and transparent reasoning. Courts increasingly expect experts to address and rebut the opposing party’s valuation arguments.

11. Practical Considerations for IP Valuers in India

  • Data limitations: Indian comparable licence data is significantly less available than in the US or Europe. Valuers must rely on international databases with appropriate geographic adjustments.
  • Regulatory environment: India’s compulsory licensing provisions (Section 84, Patents Act) and price control mechanisms (e.g., DPCO for pharmaceutical patents) can significantly affect IP value.
  • Currency considerations: For IP generating revenues in multiple currencies, forecast cash flows and discount rates must be currency-consistent.
  • Start-up IP: Valuing IP in early-stage companies — where revenues are speculative — requires scenario-based or option pricing models rather than traditional DCF.
  • Technology convergence: In sectors like telecom and IT, patents increasingly form part of standard-essential patent (SEP) pools, requiring FRAND (Fair, Reasonable, and Non-Discriminatory) licensing valuation frameworks.
Expert Tip — CA V. Viswanathan: When valuing IP for Indian companies, always consider the interaction between Ind AS 38 recognition criteria, Section 32(1)(ii) tax depreciation, and transfer pricing documentation requirements. A valuation that satisfies financial reporting standards may not withstand transfer pricing scrutiny if the DEMPE analysis is inadequate. I recommend preparing a unified valuation memorandum that addresses all three dimensions simultaneously, reducing inconsistency and audit risk.
AEO Summary: Patent and IP valuation in India employs three approaches — income (Relief from Royalty and MPEEM), market, and cost (reproduction and replacement). The Relief from Royalty method values IP as the present value of hypothetical royalty savings, requiring careful royalty rate selection from comparable licences. MPEEM isolates excess earnings attributable to the primary intangible by deducting contributory asset charges. Ind AS 38 governs intangible asset recognition; Section 32(1)(ii) allows 25% WDV depreciation on acquired IP. Transfer pricing of IP requires DEMPE analysis under OECD/BEPS guidance. WIPO guidelines recommend multi-method reconciliation for robust conclusions. IP valuation for litigation requires quantification of lost profits, reasonable royalties, or unjust enrichment.

Frequently Asked Questions

1. What is the Relief from Royalty method for patent valuation?

The Relief from Royalty (RfR) method values a patent by estimating the present value of royalty payments the owner is “relieved” from paying by owning the IP rather than licensing it. The method involves projecting revenues attributable to the patent, applying an arm’s length royalty rate, deducting applicable taxes, and discounting the after-tax royalty savings to present value using an IP-specific discount rate. It is the most widely used method for patent and trademark valuation globally.

2. How does the Multi-Period Excess Earnings Method (MPEEM) work?

MPEEM isolates the earnings attributable to a specific intangible asset by deducting fair returns (contributory asset charges) for all other assets — tangible and intangible — that contribute to the cash flow stream. The residual “excess” earnings are attributed to the subject intangible and discounted to present value. MPEEM is typically used for the primary intangible asset in a purchase price allocation, such as customer relationships or core technology.

3. Can internally generated patents be recognised as assets under Ind AS 38?

Internally generated patents can only be recognised if all six conditions of Ind AS 38.57 are satisfied during the development phase — technical feasibility, intention to complete, ability to use or sell, probable future economic benefits, availability of adequate resources, and ability to measure development costs reliably. Research phase expenditure is always expensed. Internally generated brands and customer lists are specifically prohibited from recognition under Ind AS 38.

4. What is the depreciation rate for intellectual property under Indian income tax law?

Under Section 32(1)(ii) of the Income Tax Act, 1961, intangible assets — including patents, copyrights, trademarks, licences, franchises, and similar commercial rights — are depreciable at 25% on a written-down value (WDV) basis. The depreciation is available from the year the asset is first put to use and results in the asset being substantially depreciated over approximately 8-10 years.

5. What is the DEMPE analysis in the context of IP transfer pricing?

DEMPE stands for Development, Enhancement, Maintenance, Protection, and Exploitation — the five key functions relating to intellectual property. Under OECD BEPS Action 8-10 (increasingly followed by Indian transfer pricing authorities), IP-related returns must be allocated to group entities based on their performance of DEMPE functions, asset contributions, and risk assumption — not merely based on legal ownership of the IP. A DEMPE analysis is essential for cross-border royalty payments, cost-sharing arrangements, and IP migration transactions.

Virtual Auditor | CA V. Viswanathan | IBBI Registered Valuer (Reg. No. IBBI/RV/03/2019/12333) | No. 7/5, Madley Road, T. Nagar, Chennai 600017 | virtualauditor.in | +91-44-2434-0634

Leave a Reply

Your email address will not be published. Required fields are marked *